Loss of OATP1B3 function causes Rotor syndrome: Implications for potential use of inhibitors in cancer

Por Pratt, Elias, Sissung, Tristan M., Figg, William D.
Publicado em 2012

CHIP and gp78-mediated ubiquitination of CYP3A4: Implications for the pharmacology of anticancer agents

Por Peer, Cody J, Sissung, Tristan M, Figg, William D
Publicado em 2011

Expression of OATP Family Members in Hormone-Related Cancers: Potential Markers of Progression

Por Pressler, Heather, Sissung, Tristan M., Venzon, David, Price, Douglas K., Figg, William D.
Publicado em 2011

ANDROGEN RECEPTOR VARIATION AFFECTS PROSTATE CANCER PROGRESSION AND DRUG RESISTANCE

Por McCrea, Edel, Sissung, Tristan M., Price, Douglas K., Chau, Cindy H., Figg, William D.
Publicado no Pharmacol Res (2016)

Association of ABCB1 Genotypes with Paclitaxel-mediated Peripheral Neuropathy and Neutropenia

Por Sissung, Tristan M., Mross, Klaus, Steinberg, Seth M., Behringer, Dirk, Figg, William D., Sparreboom, Alex, Mielke, Stephan
Publicado em 2006

Genetic variation: effect on prostate cancer

Por Sissung, Tristan M., Price, Douglas K., Del Re, Marzia, Ley, Ariel M., Giovannetti, Elisa, Figg, William D., Danesi, Romano
Publicado no Biochim Biophys Acta (2014)

The Role of Vascular Endothelial Growth Factor (VEGF) SNPs as Predictive and Prognostic Markers for Major Solid Tumors

Por Jain, Lokesh, Vargo, Craig A., Danesi, Romano, Sissung, Tristan M., Price, Douglas K., Venzon, David, Venitz, Jürgen, Figg, William D.
Publicado em 2009

TRANSPORTER POLYMORPHISMS AFFECT NORMAL PHYSIOLOGY, DISEASES, AND PHARMACOTHERAPY

Por Sissung, Tristan M., Troutman, Sarah M., Campbell, Tessa J, Pressler, Heather M., Sung, Hyeyoung, Bates, Susan E., Figg, William D.
Publicado em 2012

Induction of CYP3A4 by Vinblastine: Role of the Nuclear Receptor NR1I2

Por Smith, Nicola F, Mani, Sridhar, Schuetz, Erin G, Yasuda, Kazuto, Sissung, Tristan M, Bates, Susan E, Figg, William D, Sparreboom, Alex
Publicado em 2010

ABCB1 genetic variation influences the toxicity and clinical outcome of patients with androgen independent prostate cancer treated with docetaxel

Por Sissung, Tristan M., Baum, Caitlin E., Deeken, John, Price, Douglas K., Aragon-Ching, Jeanny, Steinberg, Seth M., Dahut, William, Sparreboom, Alex, Figg, William D.
Publicado em 2008

A SNP in CYP2C8 is not associated with the development of bisphosphonate-related osteonecrosis of the jaw in men with castrate-resistant prostate cancer

Por English, Bevin C, Baum, Caitlin E, Adelberg, David E, Sissung, Tristan M, Kluetz, Paul G, Dahut, William L, Price, Douglas K, Figg, William D
Publicado em 2010

Dual Targeting of the Androgen Receptor and Hypoxia-Inducible Factor 1α Pathways Synergistically Inhibits Castration-Resistant Prostate Cancer Cells

Por Fernandez, Elena V., Reece, Kelie M., Ley, Ariel M., Troutman, Sarah M., Sissung, Tristan M., Price, Douglas K., Chau, Cindy H., Figg, William D.
Publicado no Mol Pharmacol (2015)

Cytochrome 450 1B1 (CYP1B1) polymorphisms associated with response to docetaxel in Castration-Resistant Prostate Cancer (CRPC) patients

Por Pastina, Ilaria, Giovannetti, Elisa, Chioni, Aldo, Sissung, Tristan M, Crea, Francesco, Orlandini, Cinzia, Price, Douglas K, Cianci, Claudia, Figg, William D, Ricci, Sergio, Danesi, Romano
Publicado em 2010

Estrogen Receptor α and Aromatase Polymorphisms Affect Risk, Prognosis, and Therapeutic Outcome in Men with Castration-Resistant Prostate Cancer Treated with Docetaxel-Based Therap...

Por Sissung, Tristan M., Danesi, Romano, Kirkland, C. Tyler, Baum, Caitlin E., Ockers, Sandra B., Stein, Erica V., Venzon, David, Price, Douglas K., Figg, William D.
Publicado em 2011

Racial Disparities in the Association Between Variants on 8q24 and Prostate Cancer: A Systematic Review and Meta-Analysis

Por Troutman, Sarah M., Sissung, Tristan M., Cropp, Cheryl D., Venzon, David J., Spencer, Shawn D., Adesunloye, Bamidele A., Huang, Xuan, Karzai, Fatima H., Price, Douglas K., Figg, William D.
Publicado em 2012

Population pharmacokinetics of romidepsin in patients with cutaneous T-cell lymphoma and relapsed peripheral T-cell lymphoma

Por Woo, Sukyung, Gardner, Erin R., Chen, Xiaohong, Ockers, Sandra B., Baum, Caitlin E., Sissung, Tristan M., Price, Douglas K., Frye, Robin, Piekarz, Richard L., Bates, Susan E., Figg, William D.
Publicado em 2009

Phase II Study of Satraplatin and Prednisone in Patients With Metastatic Castration-Resistant Prostate Cancer: A Pharmacogenetic Assessment of Outcome and Toxicity

Por Figg, William D., Chau, Cindy H., Madan, Ravi A., Gulley, James L., Gao, Rui, Sissung, Tristan M., Spencer, Shawn, Beatson, Melony, Aragon-Ching, Jeanny, Steinberg, Seth M., Dahut, William L.
Publicado em 2013

Histone deacetylase inhibitors modulate K(ATP) subunit transcription in HL-1 cardiomyocytes through effects on cholesterol homeostasis

Por Fatima, Naheed, Cohen, Devin C., Sukumar, Gauthaman, Sissung, Tristan M., Schooley, James F., Haigney, Mark C., Claycomb, William C., Cox, Rachel T., Dalgard, Clifton L., Bates, Susan E., Flagg, Thomas P.
Publicado no Front Pharmacol (2015)

Association of the ABCG2 C421A polymorphism with prostate cancer risk and survival

Por Gardner, Erin R., Ahlers, Christoph M., Shukla, Suneet, Sissung, Tristan M., Ockers, Sandra B., Price, Douglas K., Hamada, Akinobu, Robey, Robert W., Steinberg, Seth M., Ambudkar, Suresh V., Dahut, William L., Figg, William D.
Publicado em 2008

Alcohol and Aldehyde Dehydrogenases Contribute to Sex-Related Differences in Clearance of Zolpidem in Rats

Por Peer, Cody J., Strope, Jonathan D., Beedie, Shaunna, Ley, Ariel M., Holly, Alesia, Calis, Karim, Farkas, Ronald, Parepally, Jagan, Men, Angela, Fadiran, Emmanuel O., Scott, Pamela, Jenkins, Marjorie, Theodore, William H., Sissung, Tristan M.
Publicado no Front Pharmacol (2016)